Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Embolism and CYP4F2[original query] |
---|
A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.
PLoS genetics 2009 Mar 5 (3): e1000433. Takeuchi Fumihiko, McGinnis Ralph, Bourgeois Stephane, Barnes Chris, Eriksson Niclas, Soranzo Nicole, Whittaker Pamela, Ranganath Venkatesh, Kumanduri Vasudev, McLaren William, Holm Lennart, Lindh Jonatan, Rane Anders, Wadelius Mia, Deloukas Pan |
Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients. Pharmacogenetics and genomics 2011 Mar 21 (3): 130-5. Shahin Mohamed Hossam A, Khalifa Sherief I, Gong Yan, Hammad Lamiaa N, Sallam Mohamed T H, El Shafey Mostafa, Ali Shawky S, Mohamed Mohamed-Eslam F, Langaee Taimour, Johnson Julie |
Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients. Journal of human genetics 2012 Oct 57 (10): 665-9. Pathare Anil, Al Khabori Murtadha, Alkindi Salam, Al Zadjali Shoaib, Misquith Rhea, Khan Hammad, Lapoumeroulie Claudine, Paldi Andras, Krishnamoorthy Rajagop |
Functionally Significant Coumarin-Related Variant Alleles and Time to Therapeutic Range in Chilean Cardiovascular Patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2020 4 26 1076029620909154. Rojo Mario, Roco Angela Margarita, Suarez Marcelo, Lavanderos Maria Alejandra, Verón Gabriel, Bertoglia Maria Paz, Arredondo Annabella, Nieto Elena, Rubilar Juan Carlos, Tamayo Francisca, Cruz Daniela, Muñoz Jessica, Bravo Gabriela, Salas Patricio, Mejías Fanny, Véliz Paulo, Godoy Gerald, Varela Nelson Miguel, Llull G, Quiñones Luis Ab |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: